Wendling D - Search Results

1

Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France.

Fautrel B, Woronoff-Lemsi MC, Ethgen M, Fein E, Monnet P, Sibilia J, Wendling D. Fautrel B, et al. Among authors: wendling d. Joint Bone Spine. 2005 Dec;72(6):550-6. doi: 10.1016/j.jbspin.2004.12.009. Joint Bone Spine. 2005. PMID: 15996504

2

A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.

Wendling D, Racadot E, Wijdenes J, Sibilia J, Flipo RM, Cantagrel A, Miossec P, Eschard JP, Macro M, Bertin P, Lioté F, Debiais F, Juvin R, Le Goff P, Masson C. Wendling D, et al. J Rheumatol. 1998 Aug;25(8):1457-61. J Rheumatol. 1998. PMID: 9712083 Clinical Trial.

3

Rheumatic disorders developed after hepatitis B vaccination.

Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, Juvin R, Parchin-Geneste N, Piroth C, Wendling D, Kuntz JL, Tavernier C, Gaudin P. Maillefert JF, et al. Among authors: wendling d. Rheumatology (Oxford). 1999 Oct;38(10):978-83. doi: 10.1093/rheumatology/38.10.978. Rheumatology (Oxford). 1999. PMID: 10534549

4

Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.

Lehuédé G, Toussirot E, Despaux J, Michel F, Wendling D. Lehuédé G, et al. Among authors: wendling d. Joint Bone Spine. 2002 Jun;69(4):406-8. doi: 10.1016/s1297-319x(02)00421-9. Joint Bone Spine. 2002. PMID: 12184439 Review.

5

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study.

Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Mezières M, Alexandre C, Dougados M. Breban M, et al. Among authors: wendling d. Rheumatology (Oxford). 2002 Nov;41(11):1280-5. doi: 10.1093/rheumatology/41.11.1280. Rheumatology (Oxford). 2002. PMID: 12422001 Clinical Trial.

6

Giant intraosseous cyst-like lesions in rheumatoid arthritis report of a case.

Lohse A, Carbillet JP, Onimus M, Stevenel F, Toussirot E, Wendling D. Lohse A, et al. Among authors: wendling d. Joint Bone Spine. 2003 Feb;70(1):67-70. doi: 10.1016/s1297-319x(02)00014-3. Joint Bone Spine. 2003. PMID: 12639622

7

Anti-TNF alpha therapy in spondyloarthropathy: deciding who to treat.

Wendling D. Wendling D. Joint Bone Spine. 2003 Dec;70(6):401-3. doi: 10.1016/s1297-319x(03)00117-9. Joint Bone Spine. 2003. PMID: 14667546 Review. No abstract available.

8

Anti-TNF-alpha therapy in ankylosing spondylitis.

Wendling D, Toussirot E. Wendling D, et al. Expert Opin Pharmacother. 2004 Jul;5(7):1497-507. doi: 10.1517/14656566.5.7.1497. Expert Opin Pharmacother. 2004. PMID: 15212600 Review.

9

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI). Gottenberg JE, et al. Among authors: wendling d. Ann Rheum Dis. 2005 Jun;64(6):913-20. doi: 10.1136/ard.2004.029694. Epub 2004 Nov 18. Ann Rheum Dis. 2005. PMID: 15550531 Free PMC article.

10

Patient knowledge of their disease: a French multicenter study in ankylosing spondylitis.

Claudepierre P, Flipo RM, Sibilia J, Berthelot JM, Goupille P, Cortinovis S, Cunin P, Chevalier X, Wendling D. Claudepierre P, et al. Among authors: wendling d. Joint Bone Spine. 2004 Nov;71(6):550-6. doi: 10.1016/j.jbspin.2004.09.001. Joint Bone Spine. 2004. PMID: 15589438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

655 results

Search Page